Vital Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.93 Cr
- Paid Up Capital ₹ 5.39 M
- Company Age 21 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -74.34%
- Profit Growth -83.13%
- Ebitda -104.92%
- Net Worth 0.56%
- Total Assets -3.97%
About Vital Lifesciences
Vital Lifesciences Private Limited (VLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 December 2003 and has a history of 21 years and two months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.93 Cr and a paid-up capital of Rs 5.39 M, as per Ministry of Corporate Affairs (MCA) records.
Laltaprasad Maurya, Shrigopal Bajaj, and Rajiv Bajaj serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH2003PTC143328
-
Company No.
143328
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Dec 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vital Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Laltaprasad Maurya
|
Director | 31-Mar-2006 | Current |
|
Shrigopal Bajaj
|
Director | 01-Sep-2005 | Current |
|
Rajiv Bajaj
|
Director | 01-Sep-2005 | Current |
Financial Performance of Vital Lifesciences.
Vital Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 74.34% decrease. The company also saw a substantial fall in profitability, with a 83.13% decrease in profit. The company's net worth moved up by a moderate rise of 0.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vital Lifesciences?
In 2023, Vital Lifesciences had a promoter holding of 100.00%. The company had 1 Subsidiary and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vital Laboratories Private LimitedLaltaprasad Maurya, Shrigopal Bajaj and 1 more are mutual person
-
Padma Pharmaceuticals Private LimitedShrigopal Bajaj and Rajiv Bajaj are mutual person
-
Vital Global Foundation
Shrigopal Bajaj and Rajiv Bajaj are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vital Lifesciences?
Unlock and access historical data on people associated with Vital Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vital Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vital Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
